Navy Lab 3D Prints Bioreactors for On-Demand Critical Materials

Printing the Reactor, Not Just the Product

The US Naval Research Laboratory has a problem that sounds like science fiction: how do you make critical materials in a place with no factory? Its answer is to 3D print the factory, or at least the part of it that matters most.

NRL is developing a continuous biomanufacturing system that grows useful compounds from surface-bound microbes, and it is using additive manufacturing to design and build the bioreactors that make it work. Instead of shipping a finished reactor to a remote site, the lab wants to print one there.

Why Continuous Beats Batch

Conventional biomanufacturing runs in big fermentation tanks that need heavy infrastructure and shut down between cycles. NRL's approach uses biofilm reactors, where microorganisms cling to engineered surfaces and keep producing as nutrients flow through. The cells stay dense, the reactor stays small, and the process runs for weeks or months.

The payoff is resilience. Materials get made close to where they are needed, including operational or remote environments, which lines up with Defense Department priorities for flexible biomanufacturing.

What the Reactors Can Make

Lab demonstrations already point at a wide spread of outputs: lubricant precursors, components for munitions, active pharmaceutical ingredients, bioplastics, and single-cell proteins. The same printed housing could be retuned for different microbes and targets just by changing the internal geometry.

Early work suggests some target molecules settle right inside the 3D-printed matrix, which could let a single device produce, separate, and concentrate a material at once. If that holds up, it strips out some of the most expensive downstream steps.

A Container in the Field

NRL has already shown a mobile, containerized biomanufacturing platform built inside a standard shipping container. The plan is to fold continuous production into those deployable units so strategic materials can be made near the point of need.

The research runs with the Air Force Research Laboratory and the Army's chemical biological center, and the team is testing multiple strains, reactor shapes, and production paths. The long goal is a domestic manufacturing base that does not buckle when a supply chain does.